Fildes A, Charlton J, Rudisill C, Littlejohns P, Prevost AT, Gulliford MC
The appetite suppression from semaglutide is real and well-documented
Secretagogue-induced release (CJC-1295/Ipamorelin): GH released in pulses, with peak amplitude during sleep-associated secretory windows Ipamorelin induces an acute GH pulse within 15-30 minutes of administration CJC-1295 (No DAC) extends GH elevation for approximately 30 minutes per pulse Combined administration produces amplified pulses documented in Bowers et al
Ozempic is a glucagon-like peptide-1 receptor agonist (GLP-1 RA)
Additionally, both medications carry independent side effect profiles: semaglutide commonly causes nausea, vomiting, and gastrointestinal symptoms, while phentermine may trigger insomnia, anxiety, and headaches
594 goat anti-mouse IgG1, Alexa Fluor, Invitrogen, United States) diluted in PBS containing 1% NGS were applied